Comparing Different Startegies of Positive Pressure Ventilation in Children
Condition(s) studied
Investigational drug(s) / intervention(s)
volume controlled ventilation: Pediatric patients in the VCV group (n= 30) received volume-controlled ventilation, target tidal volume was set at 7 mL/kg, with a respiratory rate of 16 breaths/min and a respiratory ratio of 1:2.
pressure controlled ventilation: Pediatric patients in the PCV group(n=30) received pressure-controlled ventilation. The initial parameters will be as follows: the peak inspiratory pressure (PIP) will set to provide a tidal volume of 7 ml/kg , respiratory rate will be 16 breaths/min, inspiratory to expiratory ratio was 1:2 with an upper limit of PIP of 20 cm H2O.
pressure controlled volume grantanteed ventilation: Pediatric patients in the PCV-VG group (n=30)will be conducted with pressure-controlled volume-guaranteed ventilation, target tidal volume will set at 7 mL/kg, with a respiratory rate of 16 breaths/min and a respiratory ratio of 1:2.
Study summary
The most basic modes of mechanical ventilation are volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV). VCV guarantees a target volume of ventilation using a constant flow, but may lead to high peak airway pressure (Ppeak) during the gas insufflation . In PCV mode, on the other hand,
Eligibility
Primary outcome measure(s)
- (PIP) — within one hour
peak inspiratory pressure - Pplat — within one hour
plateau airway pressure - (Cdyn) — within one hour
pulmonary dynamic compliance - (RAW — within one hour
airway resistance - VT — within one hour
exhaled tidal volume - EtCO2 — within one hour
end-expiratory carbon dioxide - Vd/VT — within one hour
physiologic dead space over tidal volume
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Benisuef university hospital | Benisuef | Egypt | Recruiting |
More Beni-Suef University trials in Egypt
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06612125 on ClinicalTrials.gov ↗ ← All trials in Egypt